Skip to main content
. 2020 Nov 6;11:571219. doi: 10.3389/fgene.2020.571219

TABLE 4.

SNP-array results of 1784 samples with advanced maternal age (≥35).

Age Number Normal Aneuploidy LOH CNV CNV a

P LP VOUS LB
35 299 (16.8%) 270 (90.3%) 6 (2.0%) 2 (0.7%) 21 (7.0%) 4(1.3%) 1 10 6
36 379 (21.2%) 342 (90.2%) 10 (2.6%) 1 (0.3%) 26 (6.9%) 7(1.8%) 2 13 4
37 344 (19.3%) 303 (88.1%) 18 (5.2%) 2 (0.6%) 21 (6.1%) 5(1.5%) 0 8 8
38 230 (12.9%) 211 (91.7%) 6 (2.6%) 0 (0.0%) 13 (5.7%) 1(0.4%) 2 6 4
39 170 (9.5%) 142 (83.5%) 11 (6.5%) 2 (1.2%) 15 (8.8%) 3(1.8%) 1 6 5
40 132 (7.4%) 118 (89.4%) 4 (3.0%) 1 (0.8%) 9 (6.8%) 3(2.2%) 0 2 4
≥41 230 (12.9%) 205 (89.1%) 19 (8.3%) 2 (0.9%) 4 (1.7%) 0(0.0%) 0 3 1
Total 1784 [100] 1591 (89.2%) 74 (4.1%) 10 (0.6%) 109 (6.1%) 23(1.3%) 6 48 32

aCNVs were classified into four groups according to interpretation: P, pathogenic; LP, likely pathogenic; VOUS, variation of uncertain significance; LB, likely benign. For cases with 2 CNVs including a pathogenic CNV and a VOUS CNV were listed in the P group.